Cost Burden of Hepatitis C Virus Treatment in Commercially Insured PatientsDecember 13th 2019
Rates of hepatitis C virus (HCV) treatment in a commercially insured population doubled after availability of new direct-acting antivirals. Member out-of-pocket spending was kept low while the health plan bore 99% of spending on HCV medications.
Association of Care Management Intensity With Healthcare Utilization in an All-Condition Care Management ProgramDecember 13th 2019
Higher intensity of care management in an all-condition program addressing care coordination and care barriers was associated with increased healthcare utilization among Medicaid and Medicare patients.
Benzodiazepine and Unhealthy Alcohol Use Among Adult OutpatientsDecember 13th 2019
Among outpatients who were screened for alcohol use, those with unhealthy alcohol use, women, and those who were older, white, and of lower socioeconomic status were more likely to use benzodiazepines.
Cost-Sharing Payments for Out-of-Network Care in Commercially Insured AdultsDecember 12th 2019
This study of claims among adults covered by employer-sponsored plans revealed substantial variations in out-of-network cost-sharing payments. The growth of cost sharing for nonemergent hospitalizations is concerning.
Outcome Measures for Oncology Alternative Payment Models: Practical Considerations and RecommendationsDecember 11th 2019
This review presents a set of evidence-based outcome measures for oncology alternative payment models, drawing on evidence from existing and proposed quality measures.
Preventive/Office Visit Patient Knowledge and Their Insurance Information Gathering PerceptionsDecember 9th 2019
Patients have an incomplete understanding of what constitutes no-cost preventive care services. Ease of obtaining information from insurance companies can significantly affect whether patients are charged correctly.
Catheter Management After Benign Transurethral Prostate Surgery: RAND/UCLA Appropriateness CriteriaDecember 5th 2019
This manuscript synthesizes findings from a multidisciplinary panel following the RAND/UCLA Appropriateness Method to guide standardization of urinary catheter use after transurethral prostate surgery.